| 000 | 01591 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517133222.0 | ||
| 264 | 0 | _c20180222 | |
| 008 | 201802s 0 0 eng d | ||
| 022 | _a1476-5608 | ||
| 024 | 7 |
_a10.1038/pcan.2016.66 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMathieu, R | |
| 245 | 0 | 0 |
_aPrognostic value of the new Grade Groups in Prostate Cancer: a multi-institutional European validation study. _h[electronic resource] |
| 260 |
_bProstate cancer and prostatic diseases _c06 2017 |
||
| 300 |
_a197-202 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 | _aEurope |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Grading _xmethods |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xepidemiology |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aProstate _xpathology |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xclassification |
| 700 | 1 | _aMoschini, M | |
| 700 | 1 | _aBeyer, B | |
| 700 | 1 | _aGust, K M | |
| 700 | 1 | _aSeisen, T | |
| 700 | 1 | _aBriganti, A | |
| 700 | 1 | _aKarakiewicz, P | |
| 700 | 1 | _aSeitz, C | |
| 700 | 1 | _aSalomon, L | |
| 700 | 1 | _ade la Taille, A | |
| 700 | 1 | _aRouprêt, M | |
| 700 | 1 | _aGraefen, M | |
| 700 | 1 | _aShariat, S F | |
| 773 | 0 |
_tProstate cancer and prostatic diseases _gvol. 20 _gno. 2 _gp. 197-202 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/pcan.2016.66 _zAvailable from publisher's website |
| 999 |
_c26769461 _d26769461 |
||